| |
| |
|
| Insider
Information: |
Bir Dawn Carter |
| Relationship: |
|
| City: |
Irving |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
7
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
7.0
|
| Percentage
Gain/Loss : |
0.0%
|
 497.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Reata Pharmaceuticals Inc |
RETA |
Chief Commercial Officer |
2023-09-26 |
0 |
|
0 |
Premium* |
|
|
Geron Corporation |
GERN |
|
|
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RETA |
Reata Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2023-09-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(33,805) |
0 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2023-08-16 |
4 |
S |
$168.33 |
$66,996 |
D/D |
(398) |
33,805 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2023-08-15 |
4 |
S |
$169.04 |
$136,413 |
D/D |
(807) |
34,203 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2023-07-28 |
4 |
AS |
$164.54 |
$6,581,428 |
D/D |
(40,000) |
35,010 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2023-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
75,010 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2023-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
4,125 |
35,010 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2023-05-16 |
4 |
S |
$80.96 |
$33,758 |
D/D |
(417) |
30,885 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2023-05-15 |
4 |
S |
$85.09 |
$76,070 |
D/D |
(894) |
31,302 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2023-03-07 |
4 |
S |
$85.08 |
$3,582,002 |
D/D |
(42,042) |
41,513 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2023-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
41,630 |
83,555 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2023-03-06 |
4 |
S |
$89.30 |
$4,921,619 |
D/D |
(54,954) |
41,925 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
48,370 |
96,879 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2023-03-03 |
4 |
S |
$88.25 |
$191,148 |
D/D |
(2,166) |
48,509 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
15,675 |
50,675 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
35,000 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2020-11-09 |
4 |
AS |
$150.01 |
$9,750,300 |
D/D |
(60,000) |
0 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
Chief Commercial Officer |
• – – |
2020-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
60,000 |
0 |
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
